CLPT Profile
ClearPoint Neuro, Inc., headquartered in Solana Beach, California, is a leading medical device company specializing in the development and commercialization of advanced technologies for minimally invasive brain surgery. Established in 1998 and formerly known as MRI Interventions, Inc., the company focuses on enhancing precision and safety in neurosurgical procedures through its proprietary MRI-guided platforms. ClearPoint Neuro operates primarily in the United States and is renowned for its innovations in intra-procedural imaging and navigation.
The company's flagship product is the ClearPoint system, a cutting-edge technology designed for the precise insertion of deep brain stimulation electrodes, biopsy needles, and the delivery of pharmaceuticals and laser catheters. This system leverages real-time magnetic resonance imaging (MRI) to guide these procedures, allowing for greater accuracy and reduced risk of complications. The ClearPoint system is a key tool for neurosurgeons performing intricate interventions in the brain, including treatments for neurological disorders and tumors.
In addition to its core technologies, ClearPoint Neuro offers the ClearPoint Neuro Navigation System, an MRI suite that provides comprehensive navigation and imaging support during surgical procedures. This suite enhances the surgical team's ability to perform complex brain surgeries with high precision, improving patient outcomes and operational efficiency. The company's technologies are supported by several strategic partnerships and collaborations with industry leaders and research institutions, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc., Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco.
ClearPoint Neuro's ongoing commitment to innovation and excellence in neurosurgical technology underscores its role in advancing the field of brain surgery. Through its advanced MRI-guided platforms and collaborative efforts, the company aims to address the growing need for minimally invasive solutions in neurosurgery and improve the quality of life for patients with complex neurological conditions.
|
